CD19 and neoplasm: Next, NSG mice were s.c. inoculated with the Raji cell line, a CD19+ Burkitt lymphoma cell line, to evaluate the anti‐tumor activity of CD19/CD3ε FP T cells and CD19 CAR‐T cells.